C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/14 (2006.01) C07D 401/12 (2006.01)
Patent
CA 2586265
The invention relates to novel nicotinamide pyridinureas as VEGF receptor kinase inhibitors, their production and use as pharmaceutical agents for preventing or treating diseases that are triggered by persistent angiogenesis.
L'invention porte sur de nouveaux nicotinamide pyridinureas utiles comme inhibiteurs de kinase dans le récepteur de VEGF, sur leur production et leur utilisation comme agents pharmaceutiques dans la prévention ou le traitement de maladies déclenchées par l'angiogenèse persistante.
Bohlmann Rolf
Haberey Martin
Hess-Stumpp Holger
Huth Andreas
Ince Stuart
Bayer Schering Pharma Aktiengesellschaft
Marks & Clerk
LandOfFree
Nicotinamide pyridinureas as vascular endothelial growth... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nicotinamide pyridinureas as vascular endothelial growth..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nicotinamide pyridinureas as vascular endothelial growth... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2023035